MODAG at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
MODAG takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on alpha-synuclein, the protein behind Lewy body pathology. Its work covers a PET tracer for alpha-synuclein alongside amyloid and tau co-pathology and safety and CSF seeding data for its drug candidate.
| Organization | CTAD 2026 Attendance |
|---|---|
MODAG Wendelsheim, Germany | |
German biotech developing small molecules and PET tracers that target toxic alpha-synuclein aggregates in neurodegenerative diseases. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue |
Instantly find 20 buyers from MODAG
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction